Invasive breast cancer cells exhibit increased mobility of the actin-binding protein CapG. Int. J. Cancer 2008, 122, 1476-1482.Renz M, Betz B, Niederacher D, Bender HG, Langowski J (2008) Invasive breast cancer cells exhibit increased mobility of the actin-binding protein CapG. Int J ...
There were also 7 secondary outcome analyses (all using the corticosteroid domain cohort): time to death, respiratory support–free days, cardiovascular organ support–free days, length of ICU stay, length of hospital stay, the WHO ordinal scale at 14 days, and progression to invasive mechanical...
The ability of p140Cap to down-regulate Src activity is thus a common feature for at least two cancer subtypes and may be a key event in dampening their migratory and invasive phenotype. Despite progress made in developing new therapies, the 5-year overall survival rate of high-risk NB ...
known biomarker for breast cancer is Her2 [5]; this oncoprotein is cell membrane bound but its extracellular domain is shed into circulation making it a potent biomarker used to monitor the response to treatment, and to detect recurrences in patients with diagnosed breast carcinoma [[6], [7]]...
For example, 4% of patients in the RECOVERY trial were receiving invasive mechanical ventilation, and 9% of patients in the Solidarity trial were mechanically ventilated at enrollment. On the other hand, REMAP-CAP which enrolled critically ill patients with COVID-19 receiving respiratory or ...
However, the lack of complete clinical follow-up for the cohort used in that study did not allow to assess the prognostic relevance of p140Cap expression in breast cancer. Here, we analysed p140Cap expression, by immunohistochemistry (IHC), on a consecutive cohort of 622 invasive breast ...
Patients with known 180-day mortality status differed from those with unknown status; patients with unknown status were younger, had higher frequencies of noninvasive ventilation receipt at baseline, had lower frequencies of invasive mechanical ventilation and vasopressor use at baseline, had lower Acute...
Protocol for the examination of specimens from patients with invasive carcinoma of the breast.(CAP Laboratory Improvement Programs)(Report)Lester, Susan CBose, ShikhaChen, YunnYiConnolly, James Lde Baca, Monica EFitzgibbons, Patrick LHayes, Daniel F...
Invasive breast cancerHER2 immunohistochemistryEquivocalIn 2018, the American Society of Clinical Oncology/College of American Pathologists revised the criteria for HER2 immunohistochemistry (IHC) equivocal (2+) classification in their updated guideline. We reviewed invasive breast cancer specimens originally ...
However, the lack of complete clinical follow-up for the cohort used in that study did not allow to assess the prognostic relevance of p140Cap expression in breast cancer. Here, we analysed p140Cap expression, by immunohistochemistry (IHC), on a consecutive cohort of 622 invasive breast ...